Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events. (Q54796511)

3 June 2018

title

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events. (English)

1 reference

3 June 2018

4

Antje Sucker

1 reference

3 June 2018

8

Dirk Schadendorf

1 reference

3 June 2018

7

Federico Garrido

1 reference

3 June 2018

author name string

Annette Paschen

1

1 reference

3 June 2018

Rosa María Méndez

2

1 reference

3 June 2018

Pilar Jimenez

3

1 reference

3 June 2018

Francisco Ruiz-Cabello

5

1 reference

3 June 2018

Mingxia Song

6

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 March 2003

1 reference

3 June 2018

International Journal of Cancer

published in

1 reference

3 June 2018

volume

103

1 reference

3 June 2018

issue

6

1 reference

3 June 2018

page(s)

759-767

1 reference

3 June 2018

Biological and clinical developments in melanoma vaccines

cites work

1 reference

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

MHC antigens and tumor escape from immune surveillance

21 January 2018

1 reference

HLA class I antigen abnormalities and immune escape by malignant cells.

21 January 2018

1 reference

Antigen-processing machinery breakdown and tumor growth

21 January 2018

1 reference

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

21 January 2018

1 reference

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

21 January 2018

1 reference

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

21 January 2018

1 reference

A new beta 2 microglobulin mutation found in a melanoma tumor cell line

21 January 2018

1 reference

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

21 January 2018

1 reference

The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region

21 January 2018

1 reference

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

21 January 2018

1 reference

Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131.

21 January 2018

1 reference

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

21 January 2018

1 reference

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

21 January 2018

1 reference

Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression

21 January 2018

1 reference

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants

21 January 2018

1 reference

Defective death receptor signaling as a cause of tumor immune escape

21 January 2018

1 reference

Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

21 January 2018

1 reference

Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells

21 January 2018

1 reference

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient.

21 January 2018

1 reference

The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation

21 January 2018

1 reference

Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens.

21 January 2018

1 reference

Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy

21 January 2018

1 reference

Molecular strategies to define HLA haplotype loss in microdissected tumor cells

21 January 2018

1 reference

HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix

21 January 2018

1 reference

Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen

21 January 2018

1 reference

Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviations

21 January 2018

1 reference

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

21 January 2018

1 reference

A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoter

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10906

1 reference

3 June 2018

PubMed ID

12516095

1 reference

3 June 2018